Optimizing treatment approaches for patients with cutaneous melanoma by integrating clinical and pathologic features with the 31-gene expression profile test

Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual

Jeffrey E. Gershenwald, Richard A. Scolyer, Kenneth R. Hess et al. · CA A Cancer Journal for Clinicians · 2017 · 2.3K citations · Full text

Medicine, Oncology, Surgery +17

Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma

Donald L. Morton, John F. Thompson, Nicola Mozzillo et al. · New England Journal of Medicine · 2014 · 1.5K citations · Full text

Medicine, Oncology, Surgery +16

Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial

The Lancet · 2022 · 477 citations · Full text

Medicine, Clinical Sciences, Oncology +16

Development of a Prognostic Genetic Signature to Predict the Metastatic Risk Associated with Cutaneous Melanoma

Pedram Gerami, Robert W. Cook, Jeff Wilkinson et al. · Clinical Cancer Research · 2015 · 277 citations

Medicine, Dermatology, Oncology +17

Long-Term Survival of Patients with Thin (T1) Cutaneous Melanomas: A Breslow Thickness Cut Point of 0.8 mm Separates Higher-Risk and Lower-Risk Tumors

Serigne Lo, Richard A. Scolyer, John F. Thompson · Annals of Surgical Oncology · 2018 · 181 citations

Medicine, Dermatology, Oncology +17